Brainstorm Cell Therapeutics Inc.

BCLIOTCHealthcare● Active

$0.80

+$0.05(+6.87%)

Market Cap$8827820

P/E Ratio—

52W High$1.33

52W Low$0.46

Avg Volume15K

Open$0.74

Beta0.28

Overview

Brainstorm Cell Therapeutics Inc. (BCLI) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BCLI · net income · updated Jun 9, 2026

Core profitability metrics

BCLI · net income · margin · TTM · CAGR

Net income was −$10.3M for FY2025 (fiscal year ending 2025-12-31), down 188.7% year-over-year. Net profit margin was —. Based on available data, Brainstorm Cell Therapeutics Inc. has been profitable since at least 2024.

FY2025 Net Income−$10.3M▼ -188.7% YoY

Trailing 12M (TTM)−$9.6Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-188.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2024

▸ FMP /income-statement · Annual · BCLI net income history · BCLI profit margin

Annual net income data

BCLI · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$10.3M▼ 188.7%—$0

FY2024★ First Profit$11.6M▲ +167.6%—$0

FY2023Loss−$17.2M▲ +29.2%—$0

FY2022Loss−$24.3M▲ +0.7%—$0

FY2021Loss−$24.5M▲ +23.1%—$0

Net income vs peers (Healthcare)

BCLI vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Brainstorm Cell Therapeutics Inc.YOU

BCLI

−$10.3M-188.7%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Brainstorm Cell Therapeutics Inc. (BCLI) reported net income of −$10.3M for FY2025 (fiscal year ending 2025-12-31), down 188.7% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Brainstorm Cell Therapeutics Inc. has been profitable since at least 2024. Net income reached a peak of $11.6M in FY2024. Data available for 15 fiscal years.

Brainstorm Cell Therapeutics Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Brainstorm Cell Therapeutics Inc. net worth" — the company's market capitalization is a separate figure from BCLI net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BCLI net income · 4 questions

Brainstorm Cell Therapeutics Inc. is not currently profitable on an annual basis. The company reported a net loss of $10.3M for FY2025.

is BCLI profitabledoes BCLI make a profitBCLI profitabilityBCLI profitable company

▸ Source: FMP /income-statement · GAAP · Brainstorm Cell Therapeutics Inc. · Brainstorm Cell Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026